Table 1.
Characteristic | Value |
---|---|
| |
Age (median, range) | 54 (32–77) |
Sex | |
Male | 16 |
Female | 4 |
Race | |
Asian | 1 |
White/Caucasian | 19 |
Tumor subsite | |
Base of tongue | 10 |
Tonsil | 5 |
Buccal mucosa | 1 |
Floor of mouth | 1 |
Nasal cavity | 1 |
Nasopharynx | 1 |
Unknown | 1 |
T-category | |
T0 | 1 |
T1 | 5 |
T2 | 7 |
T3 | 2 |
T4 | 5 |
N-category | |
Nx | 1 |
N1 | 11 |
N2a | 1 |
N2b | 6 |
N2c | 1 |
AJCC stage | |
I | 2 |
II | 6 |
III | 2 |
IVA | 9 |
IVB | 1 |
Therapeutic combination | |
RT alone | 3 |
RT + CC | 8 |
RT + surgery | 1 |
RT + CC + IC | 5 |
RT + CC + surgery | 1 |
RT + CC + IC + surgery | 2 |
Unless otherwise indicated, data shown correspond to patient number counts. AJCC, American Joint Committee on Cancer; RT, radiotherapy; CC, concurrent chemotherapy; IC, induction chemotherapy.